A pilot study of preoperative, single-dose ipilimumab (Ipi) and/or cryoablation (Cryo) in women (pts) with early stage/resectable breast cancer (ESBC).

Authors

Adi Diab

Adi Diab

Memorial Sloan-Kettering Cancer Center, New York, NY

Adi Diab , Stephen Barnett Solomon , Virgilio Sacchini , Christopher Comstock , Majid Maybody , Jeremy C. Durack , Janice S. Sung , Brian Blum , Deirdre A. Neville , Alan Kotin , Jianda Yuan , Sujata Patil , Elizabeth Ann Morris , Edi Brogi , Monica Morrow , Jedd D. Wolchok , Clifford Hudis , James Allison , Larry Norton , Heather L. McArthur

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT01502592

Citation

J Clin Oncol 31, 2013 (suppl; abstr TPS3120)

DOI

10.1200/jco.2013.31.15_suppl.tps3120

Abstract #

TPS3120

Poster Bd #

23G

Abstract Disclosures

Similar Posters

First Author: Elizabeth Anne Comen

Poster

2012 ASCO Annual Meeting

Surgery for patients receiving ipilimumab: Safety profile and immunological insights.

Surgery for patients receiving ipilimumab: Safety profile and immunological insights.

First Author: David E. Gyorki

First Author: Guillermo De Velasco